Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.06.204PMID 27420579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas.

  2016cited by this paper
• Editor’s Choice-Chest pain relief in patients with acute myocardial infarction

  2016cited by this paper
• Abstract 19153: Morphine Delays and Attenuates Ticagrelor Exposure and Action in Patients With Myocardial Infarction: The Randomized, Double-blind, Placebo-controlled Impression Trial

  2015cited by this paper
• Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves

  2015cited by this paper
• P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY

  2015cited by this paper
• Opioid receptors and cardioprotection – ‘opioidergic conditioning’ of the heart

  2015cited by this paper
• Morphine may enhance the cardioprotection induced by remote ischemic perconditioning.

  2015cited by this paper
• Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance.

  2014cited by this paper
• Prehospital ticagrelor in ST-segment elevation myocardial infarction.

  2014cited by this paper
• Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2014cited by this paper
• Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial.

  2014cited by this paper
• Prehospital ticagrelor in ST-segment elevation myocardial infarction.

  2014cited by this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.

  2013cited by this paper
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  2012cited by this paper
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

  2012cited by this paper
• Effect of Narcotic Treatment on Outcomes of Acute Coronary Syndromes

  2011cited by this paper
• High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

  2011cited by this paper
• Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention.

  2010cited by this paper
• Effect of narcotic treatment on outcomes of acute coronary syndromes.

  2010cited by this paper
• Acute Methadone Treatment Reduces Myocardial Infarct Size via the &dgr;-Opioid Receptor in Rats During Reperfusion

  2009cited by this paper
• Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.

  2009cited by this paper
• Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

  2008cited by this paper
• Long‐term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction

  2006cited by this paper
• Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

  2005cited by this paper
• Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

  2005cited by this paper
• A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

  2003cited by this paper
• Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

  2003cited by this paper
• TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

  2000cited by this paper
• Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction.

  1997cited by this paper
• Insights into opioid action in the intestinal tract.

  1996cited by this paper
• The thrombolysis in myocardial infarction (TIMI) trial.

  1985cited by this paper
• Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

  1985cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• Editorial note Dilated cardiomyopathy — an immunological tombstone?

  1984cited by this paper
• Inhibition of gastric emptying and drug absorption by narcotic analgesics.

  1975cited by this paper
• Calculus And Analytic Geometry

  1974cited by this paper

• Exploring the morphine-platelet activity association in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

  2024cites this paper
• Platelet inhibition with orodispersible ticagrelor in acute coronary syndromes according to morphine use: the TASTER study final results.

  2023cites this paper
• Telehealth of cardiac devices for CVD treatment

  2023cites this paper
• Evaluation of Ejection Fraction in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

  2023cites this paper
• Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: A meta-analysis of comparative studies.

  2023cites this paper
• Morphine Use Did Not Eliminate the Effect of Pain on Complications After Acute Myocardial Infarction.

  2022cites this paper
• Morphine Use in ST-Elevation Myocardial Infarction With Downstream P2Y12 Receptor Blockers—Insight From Observational Study

  2022cites this paper
• Impact of timing of morphine treatment on infarct size in experimental animal model of acute myocardial ischemia and reperfusion.

  2022cites this paper
• P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding

  2022cites this paper
• Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes

  2022cites this paper
• The Open Nursing Journal Morphine Use Did Not Eliminate the Effect of Pain on Complications After Acute Myocardial Infarction.

  2022cites this paper
• Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial.

  2021cites this paper
• Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial and pharmacodynamics of ticagrelor in patients with unstable angina and non-ST-elevation myocardial infarction and their

  2021cites this paper
• Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial

  2021cites this paper
• Smoking, alcohol and opioids effect on coronary microcirculation: an update overview

  2021cites this paper
• Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI.

  2021cites this paper
• Association between pre-hospital chest pain severity and myocardial injury in ST elevation myocardial infarction: A post-hoc analysis of the AVOID study

  2021cites this paper
• Comparison of the effect of morphine and fEntanyl in patients with acute coronary syndrome - The COMET randomized controlled trial.

  2021cites this paper
• Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction—Prevalence, Importance and Approaches to Management

  2021cites this paper
• Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association

  2021cites this paper
• Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement

  2020cites this paper
• Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.

  2020cites this paper
• Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present

  2020cites this paper
• Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction

  2020cites this paper
• Impact of Preadmission Morphine on Reinfarction in Patients With ST‐Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta‐Analysis

  2020cites this paper
• Nitrous oxide/oxygen plus acetaminophen versus morphine in ST elevation myocardial infarction: open-label, cluster-randomized, non-inferiority study

  2020cites this paper
• Cangrelor-supported primary percutaneous coronary intervention in a patient with cardiogenic shock due to left main acute occlusion.

  2020cites this paper
• Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction

  2020cites this paper
• Effects of nalbuphine on the cardioprotective effect of morphine in rats.

  2020cites this paper
• The opioid-P2Y12 inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction.

  2020cites this paper
• Morphine and myocardial ischaemia-reperfusion.

  2020cites this paper
• Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: A meta-analysis.

  2020cites this paper
• Opioids and ST Elevation Myocardial Infarction: A Systematic Review.

  2019cites this paper
• Drug-Drug Interactions in Acute Coronary Syndrome Patients: Systematic Review

  2019cites this paper
• Association of periprocedural intravenous morphine use on clinical outcomes in ST‐elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta‐analysis

  2019influential citation
• The prevalence and outcomes of morphine use in the initial management of patients with acute myocardial infarction

  2019influential citation
• Effect of morphine use on oral P2Y12 platelet inhibitors in acute myocardial infarction: Meta-analysis

  2019influential citation
• The safety of morphine use in acute coronary syndrome: a meta-analysis

  2019influential citation
• Systematic Incorporation of Sex‐Specific Information Into Clinical Practice Guidelines for the Management of ST‐Segment–Elevation Myocardial Infarction: Feasibility and Outcomes

  2019cites this paper
• Short title: Morphine impairs reperfusion pre-PPCI

  2019influential citation
• Morphine in acute coronary syndrome: systematic review and meta-analysis

  2019cites this paper
• Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?

  2019cites this paper
• 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion.

  2019cites this paper
• Risks of Opioids in ST-Elevation Myocardial Infarction: A Review

  2018cites this paper
• Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

  2018cites this paper
• Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size

  2018cites this paper